Pregnant women living with HIV showed a threefold increase in the risk for placental malaria in the context of a high viral load, based on data from more than 600 individuals. In the absence of ...
Women with HIV in British Columbia accurately self-reported viral load, unaffected by sociodemographic factors, with 91% accuracy. High concordance (91%) was found between self-reported and clinical ...
Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 trial. The study saw 114 healthy adults inoculated with the virus and then ...
Hosted on MSN
Clinical trial suggests knowing HIV 'viral load' doesn't improve number of patients seeking needed care
According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million people living with HIV in the United States, and another 1.2 to 2.2 ...
Enanta Pharmaceuticals’ respiratory syncytial virus (RSV) antiviral reduced the viral load in a phase 2 study in children, maintaining hopes the biotech can find a niche in a market now dominated by ...
Most women living with HIV achieved an immunologic response after 2 years of initiating antiretroviral therapy. A higher baseline HIV viral load increased the odds of an immunologic response in women ...
Enanta Pharmaceuticals reported that the Phase IIb trial failed to meet its primary endpoint. Image credit: viewimage / Shutterstock.com. At IDWeek 2025, held on 19–22 October, Dr John P DeVincenzo ...
According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million people living with HIV in the United States, and another 1.2 to 2.2 ...
Who gets sick? Much of COVID-19’s prevalence, severity, and lethality may have to do with viral particles you are exposed to—the issue of viral load, also called viral dose. Not much is written on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results